Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
Today, a brief rundown of news from Sanofi and Novo Nordisk, as well as updates from The Lasker Foundation, Edgewise Therapeutics and Vanda Pharmaceuticals that you may have missed. Novo Nordisk shares fell 6% in Friday trading today after reporting mixed …